Drugs & Targets FDA Approves Gilotrif Tablets for Squamous Cell Lung Cancer April 25, 2016Vol.42 No.16
Drugs & Targets University of Chicago and AbbVie to form five-year collaboration April 25, 2016Vol.42 No.16
Drugs & Targets FDA Grants Accelerated Approval to Venclexta Tablets in CLL April 18, 2016Vol.42 No.15
Drugs & Targets University of Chicago and Evelo Biosciences enters licensing agreement April 18, 2016Vol.42 No.14
Drugs & Targets Halaven receives positive opinion from CHMP in liposarcomas April 18, 2016Vol.42 No.14
